Lessons From Luxembourg V. Genzyme
As many practitioners know, securities fraud litigation can implicate thorny questions about whether and when public companies must disclose information that could potentially damage the company's stock value. Securities law strives...To view the full article, register now.
Already a subscriber? Click here to view full article